X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
humans (40) 40
female (31) 31
oncology (30) 30
middle aged (22) 22
aged (18) 18
male (17) 17
cancer (16) 16
chemistry (16) 16
metallurgy (16) 16
organic chemistry (16) 16
survival (16) 16
treatment outcome (16) 16
adult (14) 14
peptides (14) 14
carcinoma, renal cell - drug therapy (12) 12
carcinoma, renal cell - genetics (12) 12
kidney neoplasms - genetics (12) 12
antineoplastic agents - therapeutic use (11) 11
carcinoma (11) 11
sunitinib (11) 11
kidney neoplasms - drug therapy (10) 10
neoplasm metastasis (10) 10
carcinoma, renal cell - pathology (9) 9
care and treatment (9) 9
disease-free survival (9) 9
mutation (9) 9
prognosis (9) 9
aged, 80 and over (8) 8
chemotherapy (8) 8
indoles - therapeutic use (8) 8
kidney neoplasms - pathology (8) 8
metastasis (8) 8
pyrroles - therapeutic use (8) 8
analysis (7) 7
biomarkers (7) 7
breast-cancer (7) 7
hematology, oncology and palliative medicine (7) 7
ovarian cancer (7) 7
polymorphism, single nucleotide (7) 7
antineoplastic agents - adverse effects (6) 6
cancer therapies (6) 6
expression (6) 6
hypertension (6) 6
interferon-alpha (6) 6
ovarian neoplasms - pathology (6) 6
pharmacology & pharmacy (6) 6
tyrosine kinase inhibitor (6) 6
urology (6) 6
1st-line sunitinib (5) 5
bevacizumab (5) 5
biomarker (5) 5
carcinoma, ovarian epithelial (5) 5
clinical medicine (5) 5
metastases (5) 5
metastatic renal cell carcinoma (5) 5
ovarian neoplasms - genetics (5) 5
paclitaxel (5) 5
patients (5) 5
pharmacokinetics (5) 5
proportional hazards models (5) 5
prospective studies (5) 5
protein kinase inhibitors - therapeutic use (5) 5
research (5) 5
spain (5) 5
therapy (5) 5
tumors (5) 5
urology & nephrology (5) 5
women (5) 5
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
brca1 (4) 4
carcinoma, renal cell (4) 4
cytochrome p-450 cyp3a - genetics (4) 4
docetaxel (4) 4
double-blind (4) 4
efficacy (4) 4
gene expression (4) 4
genetic aspects (4) 4
health aspects (4) 4
identification (4) 4
kidney cancer (4) 4
medical and health sciences (4) 4
medical prognosis (4) 4
medicin och hälsovetenskap (4) 4
obstetrics & gynecology (4) 4
pharmacogenetics (4) 4
protein-tyrosine kinase (4) 4
research article (4) 4
single nucleotide polymorphisms (4) 4
single-nucleotide polymorphisms (4) 4
studies (4) 4
survival rate (4) 4
toxicity (4) 4
abridged index medicus (3) 3
antimitotic agents (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
association (3) 3
beer (3) 3
biochemistry (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of cancer, ISSN 0020-7136, 07/2019
mTOR pathway inhibitors are key drugs for the treatment of many tumor types, however, there are no predictive biomarkers in clinical use. Here, we performed a... 
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. e784 - e792
Background Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs, including paclitaxel. There is large interindividual variability in the... 
Comorbidities | Peripheral neuropathy | Risk factors | Concomitant medications | Paclitaxel | TAXANE-INDUCED NEUROPATHY | ACETYL-L-CARNITINE | VARIANTS | CANCER | NEUROTOXICITY | BREAST | WOMEN | ONCOLOGY | ASSOCIATION | POLYPHARMACY | Index Medicus
Journal Article
Molecular Oncology, ISSN 1574-7891, 02/2015, Volume 9, Issue 2, pp. 422 - 436
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4_suppl, pp. 450 - 450
450 Background: Pazopanib is a VEGF receptor inhibitor active in the treatment of advanced RCC treatment, and Interferon has been a long-standing treatment... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 4548 - 4548
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 411 - 411
411 Background: Although immune checkpoint inhibitors (ICI) have improved outcomes in some pts with platinum-resistant mUC, many pts (eg, pts with TCGA luminal... 
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2016, Volume 16, Issue 1, p. 135
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e15171 - e15171
Journal Article
World Journal of Clinical Oncology, ISSN 2218-4333, 05/2014, Volume 5, Issue 2, pp. 86 - 92
Uterine cervical cancer is the second most common gynecological malignancy. It is estimated that over 35% of tumors are diagnosed at locally advanced disease,... 
Neoajuvant chemotherapy | Locally advanced cervical cancer | Radiotherapy | Radical hysterectomy | Federation of Gynecology and Obstetrics stage IB2-IIB | Topic Highlight | Federation of Gynecology and Obstetrics stage IB2-IIB
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.